Congress Abstracts
1. SPELETAS M, MAMARA A, KALALA F, LIADAKI K, PAPADOULIS N, KIOUMI A, GIANNAKOULAS N, LAFIONIATIS S, LOUKIDIS K, MATSOUKA P, KARTASIS Z, GERMENIS A. TNFRSF13B gene expression and molecular analysis in B-cell chronic lymphoproliferative disorders. 14th Congress of the European Hematology Association, Berlin 2009
Haematologica 94(Suppl. 2):593, 2009
2. ZOI K, DAHABREH IJ, ZOI C, HELBIG G, KRZEMIEN S, GOTA V, SPELETAS M, GIANNOULI S, PALLIOU A, STEFANOUDAKI K, HARHALAKIS N, VASSILOPOULOS G, KOTSOPOULOU M, TSIRIGOTIS P, MOUTSOPOULOS HM, LOUKOPOULOS D, VOULGARELIS M. JAK2 V617F-positive chronic eosinophilic leukemia: Clinical, laboratory and molecular definition of a distinct disease subtype. 14th Congress of the European Hematology Association, Berlin 2009
Haematologica 94(Suppl. 2):267, 2009
3. GERMENIS AE, KARANIKAS V. Cord blood lymphocytes combating immunosenescence. ESRI 2009 7th European Congress of Reproductive Immunology, Marathon, Athens 2009
Journal of Reproductive Immunology 81:131, 2009
4. SPELETAS M, MAMARA A, IORDANAKIS G, PAPADOPOULOU-ALATAKI E, TSITSAMI E, GERMENIS AE. TACI expression and mutational status in Greek patients with common variable immunodeficiency and selective IgA deficiency. 2nd European Congress of Immunology, Berlin 2009
European Journal of Immunology 39(Suppl. S1):S457, 2009
5. SPELETAS M, GERMENIS AE. Rare diseases in Greece: Experience of a referral center. Balkan Congress for Rare Diseases, Cluj-Napoca, Romania 2009
6. SPELETAS M, BOUKAS K, PAPADOPOULOU-ALATAKI E, TSITSAMI E, GERMENIS AE. A double nucleotide substitution leading to a stop codon responsible for hereditary angioedema. 6th C1INH Deficiency Workshop, Budapest, Hungary 2009
7. SPELETAS M, TSITSAMI E, KALALA F, PAPADOPOULOS VP, MERENTITI V, MITROULIS I, RITIS K, GERMENIS AE. TLR single nucleotide polymorphisms (SNPs) distribution among familial Mediterranean fever (FMF) patients and normal individuals. Translational Research in Paediatric Rheumatology - TRiPR – Innate Immunity and the Pathogenesis of Rheumatic Diseases, Genoa, Italy, 2009
8. SPELETAS M, PAPADOPOULOU-ALATAKI E, LOULES G, IORDANAKIS G, GERMENIS AE. Novel TACI mutations (V220A and P251L) possibly not implicated in common variable immunodeficiency pathogenesis. 22st European Immunogenetics & Histocompatibility Conference, Toulouse 2008
Tissue Antigens 71:337, 2008
9. SPELETAS M, MAMARA A, KALALA F, LIADAKI K, PAPADOULIS N, KIOUMI A, GIANNAKOULAS N, LAFIONIATIS S, LOUKIDIS K, MATSOUKA P, KARTASIS Z, GERMENIS A. Leptin induces the expression of functional tissue factor in human neutrophils and peripheral blood mononuclear cells through JAK2-dependent mechanisms and TNFa involvement. 13th Congress of the European Hematology Association, Copenhagen 2008
Haematologica 93(Suppl. 1):147, 2008
10. KARANIKAS V, SPELETAS M, ZAMANAKOU M, KALALA F, LOULES G, KERENIDI T, GOURGOULIANIS KI, GERMENIS AE. Foxp3 expression in human cancer cells. American Association for Cancer Research (AACR) Annual Meeting, San Diego USA 2008
11. KARANIKAS V, SOUKOU F, KALALA F, KERENIDI T, GOURGOULIANIS KI, GERMENIS AE. Low-frequency CD8+ T cell precursors specific for survivin and survivin-2B in cancer patients: A caveat for immunotherapy? 8th International Conference on New Trends in Immunosuppression and Immunotherapy, Berlin 2008
12. KARANIKAS V, TSOHAS S, BOUKAS K, KERENIDI T, NAKOU M, DAHABREH J, POULARAKIS T, GOURGOULIANIS KI, GERMENIS AE. Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: Implications for immunotherapy. International Society for Cellular Oncology Congerss (ISCO 2008), Amsterdam 2008
Cellular Oncology 30:133, 2008
13. KARANIKAS V, SOUKOU F, ZAMANAKOU M, KALALA F, GRAMMOUSTIANOU ES, KERENIDI T, GOURGOULIANIS KI, GERMENIS AE. Quantitative and qualitative assessment of anti-tumour specific T cells in patients with lung cancer and cancer free individuals. International Society for Cellular Oncology Congerss (ISCO 2008), Amsterdam 2008
Cellular Oncology 30:134, 2008
14. KARANIKAS V, ZAMANAKOU M, KERENIDI T, DAHABREH J, HEVAS A, NAKOU M, GOURGOULIANIS KI, GERMENIS AE. Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer. 4th International Greek Biotechnology Forum (IGBF-4), Athens 2008
15. SPELETAS M, LOULES G, GERMANIDIS G, RITIS K, GERMENIS AE. Foxp3 at the crossroad οf immunoregulation, apoptosis and fibrosis in liver diseases. 4th International Greek Biotechnology Forum (IGBF-4), Athens 2008
16. SPELETAS M, GRAMMOUSTIANOU E-S, LOULES G, TSOHAS S, KALALA F, BRAIMI M, MANDALA E, KATODRITOU E, KARANIKAS V, GERMENIS AE. Overexpression of survivin and its variants in the bone marrow of patients with chronic myeloid leukaemia (CML) in remission: Restricting their use in immunotherapy? 4th International Greek Biotechnology Forum (IGBF-4), Athens 2008
17. SPELETAS M, KIOUMI A, LOULES G, KALALA F, KATODRITOU E, TSITOURIDIS I, HYTIROGLOU P, CHRISTAKIS J, KORANTZIS I, GERMENIS A. Analysis of SLC40A1 (Ferroportin 1) gene at mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV. 12th Congress of the European Hematology Association, Vienna 2007
Haematologica 92(Suppl. 1):291, 2007
18. GERMANIDIS G, LOULES G, KOUVELIS L, KARANIKAS V, GIANNOULIS E, RITIS K, GERMENIS A, SPELETAS M. mRNA expression analysis of immunoregulation, apoptosis and fibrosis in liver diseases. 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston 2007
Hepatology 46(Suppl. S):449A, 2007
19. SPELETAS M, PLASTIRAS D, KALALA F, LIADAKI K, KATODRITOU E, MANDALA E, DAIOU C, RITIS K, KORANTZIS I, GERMENIS A. Innate immunity and thrombosis: Association of TLR4-D299G and TLR4-T399I single nucleotide polymorphisms (SNPs) with thromboembolic disease in patients with myeloproliferative disorders (MPDs). 21st European Immunogenetics & Histocompatibility Conference, Barcelona 2007
Tissue Antigens 69:445, 2007
20. ROKA V, YIANNAKI E, NIKOULIS D, KOUKOULIS G, POTAMIANOS S, GERMENIS A. Prevalence of silent/subclinical celiac disease in Greece. 11th Conference of the European Society of General Medicine/Family Medicine, Kos, Greece, 2005
21. ADAM KP, PRATTI A, ZINTZARAS E, SOUKOU F, NIKOULIS D, STATIRIS C, GERMENIS AE. HLA-A, -B, and -DRB1 analysis of the mixed and two closed populations (Vlachs and Sarakatsans) of Thessaly, Greece. 19th European Immunogenetics & Histocompatibility Conference, Istanbul 2005
Genes & Immunity 6(Suppl. 1): S35, 2005
22. THRISKOS P, ZINTZARAS E, ADAM KP, GERMENIS AE. DHLAS: A web-based database system to support HLA population studies. 19th European Immunogenetics & Histocompatibility Conference, Istanbul 2005
Genes & Immunity 6(Suppl. 1):S79, 2005
23. POTOLODIS E, KOUTALA H, PYROVOLAKI K, DAMIANAKI A, GERMENIS A, ELIOPOULOS GD, PAPADAKI HA. Overexpression of Τoll-like receptors by bone marrow CD14 cells in patients with myelodysplastic syndromes. 10th Congress of the European Hematology Association, Stockholm, Sweden, 2005
Haematologica 90(Suppl. 2):356, 2005
24. LIASKOS C, ZOGRAFOS TA, TOGOUSIDIS E, ZACHOU K, GATSELIS N, RIGOPOULOU E, GERMENIS A, DALEKOS GN. Alterations of leptin levels during IFN-alpha treatment in patients with chronic viral hepatitis B and C: Evidence of an IFN-alpha-mediated suppression of leptin production. 56th Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, USA, 2005
Hepatology 42(Suppl. 1):673A, 2005
25. ZACHOU K, YIANNAKI EE, ROKA V, LIASKOS C, ADAM K, KAPSORITAKIS AN, GERMENIS AE, DALEKOS GN. Prevalence and clinical significance of IgA antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. 56th Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, USA, 2005
Hepatology 42(Suppl. 1):288A, 2005